Mardia Samyoung Capillary Tubes Company (BSE 513544)₹53.13+7.10%Copper
In the Mar 2026 quarter (standalone), Mardia Samyoung Capillary Tubes Company reported sales of ₹61.04 Cr and net profit of ₹1.16 Cr. For the year to Mar 2026, sales were ₹73.77 Cr and net profit ₹2.24 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 12.32 | 61.04 |
| Expenses | 0.07 | 0.04 | 0.10 | 0.31 | 0.28 | 1.45 | 0.04 | 0.04 | 0.24 | 0.38 | 10.45 | 59.33 |
| Operating Profit | −0.07 | −0.04 | −0.10 | −0.29 | −0.16 | −1.43 | −0.04 | −0.04 | −0.22 | 0.01 | 1.88 | 1.79 |
| OPM % | — | — | — | — | −141.6% | — | — | — | — | 4.9% | 15.3% | 3.0% |
| Other Income | 0.08 | 0.03 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.01 | −0.03 | −0.11 | −0.30 | −0.17 | −1.42 | −0.04 | −0.04 | −0.22 | 0.01 | 1.88 | 1.79 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 31.8% | 36.7% |
| Net Profit | −0.02 | −0.05 | −0.13 | −0.32 | −0.19 | −1.44 | −0.06 | −0.06 | −0.24 | 0.03 | 1.30 | 1.16 |
| EPS (Rs) | 0.00 | −0.05 | −0.16 | −0.44 | −0.25 | −2.04 | −0.06 | −0.06 | −0.32 | 0.02 | 1.84 | 0.16 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | −0.01 | 0.00 | 0.00 | −0.04 | −0.13 | 0.00 | 73.77 | 73.76 |
| Expenses | 0.41 | 0.64 | 0.36 | 0.30 | 0.30 | 0.24 | 0.38 | 0.37 | 0.44 | 1.52 | 70.39 | 70.40 |
| Operating Profit | −0.41 | −0.62 | −0.36 | −0.30 | −0.32 | −0.24 | −0.39 | −0.42 | −0.56 | −1.52 | 3.48 | 3.46 |
| OPM % | — | — | — | — | — | — | — | — | — | — | 4.8% | 4.7% |
| Other Income | 0.33 | 0.30 | −0.03 | 0.06 | 0.10 | 0.26 | 0.47 | 0.29 | 0.10 | 2.74 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.24 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.32 | −0.38 | −0.41 | −0.28 | −0.26 | −0.02 | 0.02 | −0.22 | −0.50 | 1.19 | 3.48 | 3.46 |
| Tax % | −9.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 36.2% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −0.31 | −0.40 | −0.43 | −0.30 | −0.28 | −0.04 | 0.04 | −0.24 | −0.52 | 1.21 | 2.24 | 2.25 |
| EPS (Rs) | −0.42 | −0.55 | −0.59 | −0.41 | −0.38 | −0.03 | 0.03 | −0.32 | −0.72 | 1.71 | 0.32 | 1.70 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.95 | 6.94 | 6.95 | 6.95 | 6.95 | 6.95 | 6.94 | 6.95 | 6.95 | 6.94 | 6.95 | 67.61 |
| Reserves | 9.18 | 8.88 | 8.50 | 7.66 | −1.53 | −1.80 | −1.83 | −1.79 | −2.02 | −2.53 | −1.33 | 26.04 |
| Borrowings | 0.66 | 0.02 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.84 | 0.00 | 0.00 |
| Other Liabilities | 2.43 | 3.29 | 2.29 | 2.41 | 2.37 | 2.59 | 2.58 | 2.80 | 3.01 | 1.57 | 0.11 | 1.36 |
| Total Liabilities | 19.22 | 19.13 | 17.75 | 17.04 | 7.79 | 7.74 | 7.70 | 7.97 | 7.96 | 6.82 | 5.73 | 95.01 |
| Fixed Assets | 3.15 | 2.92 | 2.79 | 2.24 | 2.12 | 2.09 | 2.06 | 2.04 | 2.01 | 2.53 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 16.07 | 16.21 | 14.96 | 14.80 | 5.67 | 5.65 | 5.64 | 5.93 | 5.95 | 4.29 | 5.73 | 95.01 |
| Inventories | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 6.01 |
| Trade receivables | 4.01 | 3.01 | 3.01 | 3.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 2.01 | 56.13 |
| Cash & equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 |
| Total Assets | 19.22 | 19.13 | 17.75 | 17.04 | 7.79 | 7.74 | 7.70 | 7.97 | 7.96 | 6.82 | 5.73 | 95.01 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −6.12 | −0.47 | −0.47 | −0.23 | −0.33 | 0.02 | 0.00 | −0.07 | −2.54 | −85.89 |
| Cash from investing activity | 0.02 | 0.00 | 0.49 | 0.28 | 0.59 | 0.00 | −0.02 | −0.55 | 2.55 | −0.02 |
| Cash from financing activity | 5.65 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 85.84 |
| Net cash flow | −0.44 | −0.20 | 0.01 | 0.04 | 0.25 | 0.00 | 0.00 | −0.59 | 0.00 | 0.11 |
| Capex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 | 0.00 | 0.00 |
| Free cash flow | −6.10 | −0.45 | −0.05 | 0.02 | −0.28 | 0.02 | −0.02 | −0.59 | 0.02 | −85.73 |
| CFO / OP % | 670.9% | 109.9% | 73.0% | 58.9% | 103.0% | −3.0% | 0.0% | 10.9% | 165.0% | −2,419.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | — | — | — | — | — | −14,235 | — | −39,420 | −7,884 | 0 | — | 275 |
| Inventory days | 3,686 | — | 1,109 | — | — | −13,871 | — | 13,504 | 3,858 | −1,930 | — | 30 |
| Days payable | 218 | — | 57 | — | — | — | — | 7,482 | 3,336 | — | — | 0 |
| Cash conversion cycle | — | — | — | — | — | −28,105 | — | −33,398 | −7,363 | −1,929 | — | 305 |
| Working capital days | — | — | — | — | — | 27,922 | — | 60,225 | 10,439 | −1,695 | — | 446 |
| ROCE % | −5.9% | −2.0% | −2.7% | −2.6% | −3.4% | −5.1% | −0.6% | 0.6% | −3.5% | −10.0% | 22.7% | 7.1% |
For the Mar 2026 quarter, Mardia Samyoung Capillary Tubes Company reported sales of ₹61.04 Cr and net profit of ₹1.16 Cr. The operating margin was 3.0%.
Mardia Samyoung Capillary Tubes Company's sales for the year to Mar 2026 were ₹73.77 Cr; over the last twelve months they were ₹73.76 Cr.
Net profit for the year to Mar 2026 was ₹2.24 Cr, and ₹2.25 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.70.
Mardia Samyoung Capillary Tubes Company reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.
Cash from operations was −₹85.89 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹85.73 Cr.